This month we present our second annual life sciences trend report for Taiwan. The Taiwanese market is characterized by a strong presence of big pharma and a high percentage of publicly listed companies – nearly one in third life science enterprises in this country is listed on a stock market. There are around 200 biotech companies and one significant financing round was already noted this year.
Would you like to be notified about new reports and other valuable content published by Biotechgate?